T., Hurwitz, S., Mossey, C
The medication does part of the work but what you eat decides whether you lose weight steadily, suffer nausea for weeks, or end up regaining everything the moment you stop the injections
Disclosures: Rohit Loomba, MD, is a consultant or advisory board member for Aardvark Therapeutics, Altimmune, Anylam/Regeneron, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Bristol-Myer Squibb, CohBar, Eli Lilly, Galmed, Gilead, Glympse bio, Hightide, Inipharma, Intercept, Inventiva, Ionis, Janssen Inc., Madrigal, Metacrine, Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Merck, Pfizer, Sagimet, Theratechnologies, 89 bio, Terns Pharmaceuticals and Viking Therapeutics
For example, earlier this year the FDA approved the use of Wegovy for reducing the risk of heart attacks, strokes, and other cardiovascular events for people who are overweight or obese
Participants received either a once-weekly 2.4 mg dose of semaglutide or placebo, along with regular lifestyle counseling focused on healthy eating and physical activity
Please see the above video about performing a subcutaneous injection
